Superworth

Danaher forward PE DHR

Share price divided by analysts' consensus earnings for the next twelve months, since 1996.

Today, Oct 23, 2026
25.4×
10-year median
25.6×
Against its 10-year history
45th
percentile: 0 is its lowest day, 100 its highest
10-year range
17.9× to 39.6×
Peer median
27.8×

Danaher's forward PE is 25.4× as of Oct 23, 2026.

That is below its ten-year median of 25.6×, close to the middle of its last ten years.

Over that time it ranged from 17.9× in Aug 2017 to 39.6× in Aug 2024.

The median for 10 diagnostics and research stocks of a similar size is 27.8×.

Forward PE over time

The dashed line is the 10-year median and the shaded band the middle half of its days.

Open the interactive chart, with overlays and comparisons

Year by year

YearEnd of yearLowHigh
2026 so far25.4×19.0×30.3×
202529.3×24.1×34.4×
202432.3×32.0×39.6×
202334.2×24.8×34.2×
202226.6×22.5×29.1×
202129.7×22.4×30.3×
202025.1×20.5×30.6×
201928.7×19.4×28.8×
201819.7×18.8×22.4×
201720.0×17.9×20.4×
201618.7×11.8×20.2×
201513.1×12.0×14.3×
201414.5×12.5×14.9×
201314.7×11.7×14.7×
201211.3×10.3×11.9×
201110.3×9.4×13.3×
201012.4×10.0×12.9×
200912.6×9.7×12.8×
200810.8×9.9×15.4×
200714.5×12.5×14.5×

Against its peers

Companies in Medical - Diagnostics & Research nearest Danaher's size, closest first, today.

Where Danaher ranks

What the forward PE tells you

Price divided by what analysts expect the company to earn over the next twelve months. It answers "what am I paying for next year" instead of last year.

Estimates are opinions. When forward PE is far below trailing PE, analysts expect a big jump in earnings. If that jump slips, the stock was not as cheap as it looked.

More on Danaher

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.